Nutra Pharma Corporation is a biopharmaceutical company that is involved in the acquisition, licensing and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, and autoimmune and infectious diseases. The company owns and operates ReceptoPharm, which develops therapeutic protein products for the prevention and treatment of viral and neurological diseases, including multiple sclerosis, adrenomyeloneuropathy, and HIV and AIDS in humans. ReceptoPharm s manufacturing and laboratory facility has achieved ISO class 5 certification. Nutra Pharma Corporation also operates Designer Diagnostics, which markets and sells diagnostic test kits for infectious diseases. The parent company offers support services for various nonprofit health care organizations, such as the Health On the Net Foundation, AIDS-Care-Watch Campaign and Stop TB Partnership.